Please rate the effectiveness of the faculty *

	High	Above Average	Average	Below Average	Low
John Marshall, MD	John Marshall, MD - High	John Marshall, MD - Above Average	John Marshall, MD - Average	John Marshall, MD - Below Average	John Marshall, MD - Low
Robin Sommers, NP, DNP, ANP-BC, AONCP	Robin Sommers, NP, DNP, ANP-BC, AONCP - High	Robin Sommers, NP, DNP, ANP-BC, AONCP - Above Average	Robin Sommers, NP, DNP, ANP-BC, AONCP - Average	Robin Sommers, NP, DNP, ANP-BC, AONCP - Below Average	Robin Sommers, NP, DNP, ANP-BC, AONCP - Low

As a result of participating in this activity, I am better able to *

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Restate the current standard of care options for the first-line mCRC therapy, using chemotherapy in combination with targeted agents	Restate the current standard of care options for the first-line mCRC therapy, using chemotherapy in combination with targeted agents - Strongly Agree	Restate the current standard of care options for the first-line mCRC therapy, using chemotherapy in combination with targeted agents - Agree	Restate the current standard of care options for the first-line mCRC therapy, using chemotherapy in combination with targeted agents - Neutral	Restate the current standard of care options for the first-line mCRC therapy, using chemotherapy in combination with targeted agents - Disagree	Restate the current standard of care options for the first-line mCRC therapy, using chemotherapy in combination with targeted agents - Strongly Disagree
Identify which patients should undergo mutation testing, and understand how these results impact selection of therapy	Identify which patients should undergo mutation testing, and understand how these results impact selection of therapy - Strongly Agree	Identify which patients should undergo mutation testing, and understand how these results impact selection of therapy - Agree	Identify which patients should undergo mutation testing, and understand how these results impact selection of therapy - Neutral	Identify which patients should undergo mutation testing, and understand how these results impact selection of therapy - Disagree	Identify which patients should undergo mutation testing, and understand how these results impact selection of therapy - Strongly Disagree
Assess the potential utility of other predictive biomarkers	Assess the potential utility of other predictive biomarkers - Strongly Agree	Assess the potential utility of other predictive biomarkers - Agree	Assess the potential utility of other predictive biomarkers - Neutral	Assess the potential utility of other predictive biomarkers - Disagree	Assess the potential utility of other predictive biomarkers - Strongly Disagree
Update the incorporation of biologics into the management of colorectal cancer	Update the incorporation of biologics into the management of colorectal cancer - Strongly Agree	Update the incorporation of biologics into the management of colorectal cancer - Agree	Update the incorporation of biologics into the management of colorectal cancer - Neutral	Update the incorporation of biologics into the management of colorectal cancer - Disagree	Update the incorporation of biologics into the management of colorectal cancer - Strongly Disagree
Discuss indications for and potential benefits of radiation therapy in patients with unresectable disease	Discuss indications for and potential benefits of radiation therapy in patients with unresectable disease - Strongly Agree	Discuss indications for and potential benefits of radiation therapy in patients with unresectable disease - Agree	Discuss indications for and potential benefits of radiation therapy in patients with unresectable disease - Neutral	Discuss indications for and potential benefits of radiation therapy in patients with unresectable disease - Disagree	Discuss indications for and potential benefits of radiation therapy in patients with unresectable disease - Strongly Disagree
Compare the potential benefits and limitation of oral cancer therapy for mCRC	Compare the potential benefits and limitation of oral cancer therapy for mCRC - Strongly Agree	Compare the potential benefits and limitation of oral cancer therapy for mCRC - Agree	Compare the potential benefits and limitation of oral cancer therapy for mCRC - Neutral	Compare the potential benefits and limitation of oral cancer therapy for mCRC - Disagree	Compare the potential benefits and limitation of oral cancer therapy for mCRC - Strongly Disagree

Please rate your level of agreement with the following statements *

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
This activity met my educational needs, expectations, and objectives	This activity met my educational needs, expectations, and objectives - Strongly Agree	This activity met my educational needs, expectations, and objectives - Agree	This activity met my educational needs, expectations, and objectives - Neutral	This activity met my educational needs, expectations, and objectives - Disagree	This activity met my educational needs, expectations, and objectives - Strongly Disagree
This activity was relevant to my practice	This activity was relevant to my practice - Strongly Agree	This activity was relevant to my practice - Agree	This activity was relevant to my practice - Neutral	This activity was relevant to my practice - Disagree	This activity was relevant to my practice - Strongly Disagree
I feel confident treating patients in my practice based on this activity	I feel confident treating patients in my practice based on this activity - Strongly Agree	I feel confident treating patients in my practice based on this activity - Agree	I feel confident treating patients in my practice based on this activity - Neutral	I feel confident treating patients in my practice based on this activity - Disagree	I feel confident treating patients in my practice based on this activity - Strongly Disagree
This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months	This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months - Strongly Agree	This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months - Agree	This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months - Neutral	This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months - Disagree	This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months - Strongly Disagree
The presentation was scientifically sound and free of commercial bias or influence	The presentation was scientifically sound and free of commercial bias or influence - Strongly Agree	The presentation was scientifically sound and free of commercial bias or influence - Agree	The presentation was scientifically sound and free of commercial bias or influence - Neutral	The presentation was scientifically sound and free of commercial bias or influence - Disagree	The presentation was scientifically sound and free of commercial bias or influence - Strongly Disagree

If you thought the presentations were commercially biased, please explain

For you, was the educational level of this activity *

Too basic

Appropriate

Too advanced

Of all of the patients that you see per month, how many are likely to be impacted by the information that you acquired in this CE/CME activity? (example: 50) *

Based upon your participation in this activity, choose the statements that apply *

I plan to implement new strategies/ skills/ information

I gained new strategies/ skills/ information that I can apply to my area of practice

I need more information before I can implement new strategies/ skills/ information

My current practice is consistent with the information presented

This topic is not within my scope of practice

I do not agree with the information presented

What, if any, additional changes do you plan to implement into your practice?

My confidence level in being able to implement these changes is *

Very confident

Somewhat confident

Uncertain

Little confidence

No confidence

Not Applicable

If you consider a change in practice, please check any barriers to overcome before initiating that change *

Organizational constraints

Formulary issues

Patient reluctance to change

Patient nonadherence

Insufficient time

Financial/Insurance

Do not know enough about the recommendations to change yet

What still remains unanswered for you?

Additional comments

Leave this field blank